| Literature DB >> 27523419 |
P Maingon1, P Blanchard2, F Bidault3, L Calmels4.
Abstract
Nasapharyngeal carcinoma is a rare disease. Oftenly, the diagnostic is made for advanced disease. Localized tumors, T1 or T2 NO observed a good prognosis and are locally controlled in more than 90 % of the cases by radiotherapy alone. The standard treatment of locally advanced disease is combined chemoradiation. A special vigilance of fast decrease of the volume of the pathological lymph nodes, sometimes associated to loss of weight might indicate an adaptive dosimetric revision. The treatment of recurrent disease is of great importance. Surgical indications are limited but should be discussed in multidisciplinary tumor board when possible. Surgical nodal sampling has to be proposed for nodal recurrence as well as reirradiation, which could be indicated according to the technical issues.Entities:
Keywords: Adaptive radiotherapy; Chemoradiation; Intensity modulated radiotherapy; Nasopharynx; Radio-chimiothérapie; Radiothérapie adaptative; Radiothérapie avec modulation d’intensité
Mesh:
Year: 2016 PMID: 27523419 DOI: 10.1016/j.canrad.2016.07.031
Source DB: PubMed Journal: Cancer Radiother ISSN: 1278-3218 Impact factor: 1.018